Multiple signaling and metabolic proteins

Multiple signaling and metabolic proteins is a non-specific designation used to describe a heterogeneous group of biological molecules involved in cellular communication and biochemical pathways (Source: PubMed, PMID: 30673016). This term does not refer to a single, well-defined therapeutic target but is instead a collective label for drugs that exhibit pleiotropic effects across various systems, such as metformin or aspirin (Source: NIH, StatPearls). For example, metformin modulates several pathways including the AMPK signaling cascade and mitochondrial complex I to exert its metabolic effects (Source: PubMed, PMID: 28111298). Because this classification encompasses a wide range of enzymes, receptors, and transporters, it lacks the molecular specificity required for standard target-based drug discovery or precision medicine. In pharmacological databases, such a label typically indicates that a drug's mechanism of action involves a complex network of interactions rather than a single primary target (Source: ChEMBL). Consequently, this entry is considered incorrect or too broad for structured target identification as it does not identify a unique, singular biological entity.

Other names

Multi-targetPleiotropic targetsNon-specific metabolic targets

Pleiotropic modulation of multiple intracellular signaling pathways and metabolic enzymes, often involving the simultaneous regulation of energy-sensing kinases and inflammatory mediators.